Why NKO?
Why NKO?
What Are Krill?
NKO and your Health
NKO Advantages
Your stories
In the press
Recommended usage
About Neptune
About Neptune
Our Subsidiaries
Board of directors
Management team
Press Releases
Our Business
Our Business
Products
Regulatory affairs
Events
The Market
Healthcare Professionals
Investors
Message from the President
Financial reports
Annual reports
Webcasts
English Canada
English
NTB (TSX)
CAN$
NEPT (NASDAQ)
US$
Stock exchange
Home
/
About Neptune
/
Press Releases
Press Releases
Neptune Reports Second Quarter Results
- pdf
on
15/10/2012
Neptune Confirms Dividend Ratio for Partial Spin-Off of NeuroBioPharm Inc.
- pdf
on
04/10/2012
Neptune Dismisses Aker’s Inaccurate Allegations About Its New Patent
- pdf
on
03/10/2012
Neptune Files a Second Patent Infringement Suit Against Competitors Aker, Enzymotec, and Others
- pdf
on
02/10/2012
Neptune Secures Another U.S. Patent
- pdf
on
01/10/2012
Neptune Announces Pricing of US$30 million Offering of Common Shares
- pdf
on
25/09/2012
Neptune Announces Proposed Offering of Common Shares
- pdf
on
24/09/2012
ECO Krill Oil Specifications Sheet
- pdf
on
20/09/2012
Neptune Krill Oil Specifications Sheet
- pdf
on
20/09/2012
Neptune Reports Preliminary Revenues on Second Quarter
- pdf
on
11/09/2012
Neptune Announces Dividend-In-Kind and Record Date for Partial Spin-Off of NeuroBioPharm Inc.
- pdf
on
07/09/2012
Neptune’s Competitor Claims an Illusory Victory
- pdf
on
06/09/2012
Neptune & Acasti Reappoint The Howard Group as Investor Relations Consultant
- pdf
on
28/08/2012
Neptune Reports First Quarter Results
- pdf
on
16/07/2012
ASIAN Market Exceptional Growth Boosting Neptune’s Sales
- pdf
on
21/06/2012
Neptune’s Allowance of Continuation of ‘348 Patent Strengthens Its Position in the U.S.
- pdf
on
07/06/2012
Neptune Reports Preliminary Revenues on First Quarter
- pdf
on
05/06/2012
Neptune to Hold Conference Call
- pdf
on
30/05/2012
Neptune Reports Fiscal 2012 Results
- pdf
on
25/05/2012
Neptune’s Board of Director Welcomes Dr. Harlan Waksal
- pdf
on
23/05/2012
Neptune Believes the Australian Patent Office Will Reconsider its Grant of Aker’s Australian Patent
- pdf
on
22/05/2012
Neptune, the Only Krill Oil Manufacturer Certified as “Friend of the Sea”
- pdf
on
22/05/2012
Neptune Confirms its Pre-eminence in the Australian Market
- pdf
on
08/05/2012
NKO
®
Ambassador John Elway to Speak at SupplySide MarketPlace (NYC) and to Visit Neptune’s Booth
- pdf
on
03/05/2012
Neptune Signs John Elway, NFL Hall-of-Famer, as Official Brand Ambassador
- pdf
on
27/03/2012
Neptune Appoints New IR firm for the US
- pdf
on
27/03/2012
Neptune Technologies & Bioressources investing over $20M in Sherbrooke
- pdf
on
09/03/2012
Neptune Technologies & Bioressources Investing Over $20M in Sherbrooke
- pdf
on
09/03/2012
Neptune to Present at The 24th Annual Roth Conference
- pdf
on
06/03/2012
Neptune Must Again Rectify Competitor’s Misleading Statement
- pdf
on
01/03/2012
Neptune Premium Krill Oil, NKO
®
Enters the Mass Market with Jamieson Laboratories, the Largest Brand in Canada
- pdf
on
15/02/2012
Neptune Acquires Common Shares of Acasti Pharma
- pdf
on
13/02/2012
Neptune, Aker and Schiff Agree to Stay of Litigation during Patent Re-examination Proceedings
- pdf
on
02/02/2012
Neptune Reports Third Quarter Results
- pdf
on
17/01/2012
Neptune Pursues its IP Strategy with Continuation Applications
- pdf
on
12/01/2012
Neptune To Hold Conference Call
- pdf
on
11/01/2012
ERRATUM - Neptune To Hold Conference Call
- pdf
on
11/01/2012
Neptune Starts Phase-I Sherbrooke Plant Expansion
- pdf
on
12/12/2011
Neptune Reports Preliminary Revenues on Record Quarter
- pdf
on
01/12/2011
Neptune Technologies & Bioressources Common Shares Graduate to the TSX
- pdf
on
24/11/2011
Neptune reaffirms its confidence in its patent protection and the US prosecution process
- pdf
on
17/11/2011
Neptune Technologies & Bioressources Announces the Inssuance of an Additional Key US Patent
- pdf
on
16/11/2011
Neptune Receives TSX Conditional Approval
- pdf
on
27/10/2011
Neptune Reports Second Quarter Results
- pdf
on
13/10/2011
Neptune Launches Patent Infringement Litigation against Aker Biomarine ASA, Enzymotec Ltd., and Others
- pdf
on
06/10/2011
Neptune Technologies & Bioressources Obtains New Patent Directed to Compositions of Omega-3 Fatty Acid Phospholipids including Krill Oil
- pdf
on
05/10/2011
Neptune To Hold Conference Call
- pdf
on
04/10/2011
Neptune’s customer is awarded “Product of the Year 2011” in Denmark
- pdf
on
28/09/2011
Neptune penetrates Asia by partnering with Chinese SKFC, the world's largest fleet owner of fishing Vessels
- pdf
on
19/09/2011
Neptune subscirbes to Acasti Pharma’s rights offering
- pdf
on
19/09/2011
Neptune Reports First Quarter Results
- pdf
on
16/08/2011
Neptune Technologies & Bioressources Confirms Dividend of Acasti Rights
- pdf
on
06/07/2011
Neptune Technologies & Bioressources Inc. welcomes Dr. Anthony Holler to its Board of Directors
- pdf
on
05/07/2011
Neptune Secures and Increases US Food, Drug, Mass and Club Distribution
- pdf
on
22/06/2011
Neptune Stronger in Asia by Penetrating the Indian Market
- pdf
on
06/06/2011
Neptune Reports Fiscal 2011 Results
- pdf
on
30/05/2011
Neptune Technologies & Bioressources Closes Oversubscribed Private Placement Financing
- pdf
on
13/05/2011
Neptune Technologies & Bioressources Environmental Responsibility and Business Conduct Acknowledged by NSF International
- pdf
on
09/05/2011
Neptune Technologies & Bioressources Secures an additional $2.865M
- pdf
on
20/04/2011
Neptune Technologies & Bioressources Announces a Private Placement Financing of Approximately $10Million USD
- pdf
on
19/04/2011
Neptune is Nominated as a Finalist forthe Nutraceutical & Business Technology Awards 2011 and Prolongs US IR Agreement
- pdf
on
14/04/2011
Bayer Healthcare’s Artic Wonder Market Test Succeeds with Neptune Krill Oil Leading to US National Launch
- pdf
on
08/04/2011
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. Shares to Trade on the TSX-Venture on March 31st
- pdf
on
30/03/2011
Neptune Reports on Preliminary 2011 Year End Results
- pdf
on
22/03/2011
Neptune Technologies & Bioressources Inc. to Present at the Roth OC Growth Stock Conference
- pdf
on
28/02/2011
Neptune Technologies & Bioressources Inc. Reports Net Profit for the Third Quarter
- pdf
on
13/01/2011
Neptune Technologies & Bioressources Inc. to Host Management Discussion Teleconference at 9:00 a.m. on January 14th
- pdf
on
12/01/2011
Neptune Technologies & Bioressources Announces A Private Placement of $2,646,500
- pdf
on
12/10/2010
Neptune Technologies & Bioressources Inc. Announces Major Breakthrough in the Omega-3 Market
- pdf
on
29/09/2010
Neptune Technologies & Bioressources Inc. subsidiary Acasti Pharma Inc. reports superior effect of Drug Candidate CaPre™ over Lovaza
®
- pdf
on
22/09/2010
Neptune Appoints IR firm for the US
- pdf
on
20/09/2010
Neptune Reports Net Profit for the First Quarter
- pdf
on
14/07/2010
Neptune Announces Cancellation of Financing
- pdf
on
15/06/2010
Neptune Reports Fiscal 2010 Results
- pdf
on
28/05/2010
NKO
®
Awarded Best Product of 2010
- pdf
on
26/05/2010
Neptune Announces Brokered $15.0 Million Private Placement Financing
- pdf
on
04/05/2010
Acasti Pharma Inc. to present at the ATVB 2010 council of the American Heart Association
- pdf
on
08/04/2010
Neptune Reports Preliminary 2010 Year End Sales Results and Acasti Nomination
- pdf
on
04/04/2010
Neptune Technologies & Bioressources Inc. named as part of 2010 TSX Venture 50
- pdf
on
03/03/2010
Neptune Technologies & Bioressources Reports Third Quarter Results
- pdf
on
14/01/2010
About Neptune
Our Subsidiaries
Board of directors
Management team
Press Releases